132981-23-8

Basic information

• Product Name: 4-tert-butylbenzoyl isocyanate
• Synonyms: 4-tert-butylbenzoyl isocyanate
• CAS NO: 132981-23-8
• Molecular Weight: 203.241
• Mol File: 132981-23-8.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 4-tert-butylbenzoyl isocyanate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-tert-butylbenzoyl isocyanate(132981-23-8)
• EPA Substance Registry System: 4-tert-butylbenzoyl isocyanate(132981-23-8)

Safety Data

• Hazardous Substances Data: 132981-23-8(Hazardous Substances Data)

Upstream product

• 1710-98-1 p-tert-butyl benzoyl chloride 
• 98-73-7 4-(1,1-dimethylethyl)benzoic acid 
• 917-61-3 sodium isocyanate 
• 3315-16-0 silver cyanate 
• 79-37-8 oxalyl dichloride 
• 56108-12-4 4-tert-butylbenzamide 

Downstream Products

• 1050349-91-1 N-(β-D-glucopyranosyl)-N'-(4-tert-butylbenzoyl)urea 
• 1050349-33-1 N-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-N'-(4-tert-butylbenzoyl)urea 
• 1235975-78-6 6-[3-(4-tert-butyl-benzoyl)-ureido]-hexanoic acid methyl ester 
• 132981-12-5 1-(4-tert-Butyl-benzoyl)-3-[(S)-3-(2,3,5,6-tetrahydro-imidazo[2,1-b]thiazol-6-yl)-phenyl]-urea 

Relevant articles and documents

Application of acylthiourea compound in preparation of medicines for resisting enterovirus

The invention discloses an application of an acylthiourea compound in preparation of an anti-enterovirus drug, and belongs to the technical field of medicines. The structure of the acylthiourea compound of the present invention is as shown in the general

NOVEL THIOUREA OR UREA DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS, CONTAINING SAME AS ACTIVE INGREDIENT

Disclosed are novel thiourea or urea derivatives inhibitory of HIV activity. Also provided are a method for preparing the thiourea or urea derivatives, and a pharmaceutical composition for the prophylaxis or therapy of AIDS comprising the derivatives. Hav

P53 ACTIVATING COMPOUNDS

The present invention relates to compounds which acivate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).